BioCentury
ARTICLE | Company News

Monash University, 60 Degrees Pharmaceuticals deal

January 26, 2015 8:00 AM UTC

Monash University granted 60 Degrees’ 60P Australia Pty. Ltd. subsidiary exclusive rights to develop fenretinide to treat dengue fever. The synthetic retinoid derivative has been evaluated as a treatm...